Federal officials are targeting the blockbuster drugs as part of their ongoing initiative to lower drug costs.

The Biden administration announced Friday that Ozempic, Wegovy and 13 additional drugs will now be covered under Medicare ...

The talks on drugs including Novo Nordisk's Wegovy, GSK's Trelegy Ellipta, and Pfizer's Xtandi will set Medicare prices that ...

Medicare will soon start paying lower prices for Novo Nordisk’s weight- loss drug Wegovy and its Type 2 diabetes treatment ...

Novo Nordisk expects Ozempic, which has been on the market since 2017, will be on Medicare's list of drugs to negotiate prices concessions, Bloomberg reported. The company told USA TODAY that it would ...

The Centers for Medicare & Medicaid Services says the 15 drugs are Ozempic, Rybelsus and Wegovy; Trelegy Ellipta; Xtandi; ...

The U.S. government on Friday announced a list of 15 prescription medicines targeted for Medicare price negotiations for 2027 ...

Medicare Advantage and Part D plans are sold by private insurance companies. Each plan sets its own cost ... cover GLP-1 receptor agonists like liraglutide (Victoza), semaglutide (Wegovy, Ozempic ...

Your out-of-pocket costs with Medicare Advantage (Part C) will depend on your individual plan. Medicare does not cover the cost of bunion correction surgery for purely cosmetic reasons.

Weight loss drugs like Ozempic and Wegovy ... or 4), your portion of costs will be higher. For example, you could pay about 25% to 50% of the drug's full price. Wegovy could be covered by some ...

HHS adds 15 drugs to Medicare Part D price negotiations, targeting cost reductions under the Inflation Reduction Act. New ...